Biocryst Pharmaceuticals Inc (BCRX)

Feb 21, 2025

BIOCRYST PHARMACEUTICALS Earnings Preview: Recent $BCRX Insider Trading, Hedge Fund Activity, and More - Nasdaq

Feb 21, 2025

Feb 21, 2025

BioCryst Pharmaceuticals (BCRX) Expected to Announce Quarterly Earnings on Monday - MarketBeat

Feb 21, 2025

Feb 21, 2025

T-cell Lymphoma Market Generated Opportunities, Future Scope - openPR

Feb 21, 2025

Feb 20, 2025

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Shares Sold by Rice Hall James & Associates LLC - MarketBeat

Feb 20, 2025

Feb 20, 2025

Savant Capital LLC Decreases Stake in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) - Defense World

Feb 20, 2025

Feb 20, 2025

BioCryst to Present at Upcoming Investor Conferences - GlobeNewswire

Feb 20, 2025

Feb 19, 2025

BioCryst Pharmaceuticals (NASDAQ:BCRX) Sets New 12-Month HighStill a Buy? - MarketBeat

Feb 19, 2025

Feb 19, 2025

BioCryst to Present at Upcoming Investor Conferences - GlobeNewswire Inc.

Feb 19, 2025

Feb 19, 2025

Analysts Set BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Price Target at $15.50 - MarketBeat

Feb 19, 2025

Feb 18, 2025

BioCryst stock soars to 52-week high, touches $9.02 - MSN

Feb 18, 2025

Feb 18, 2025

JMP Securities maintains BioCryst stock with $18 target By Investing.com - Investing.com Canada

Feb 18, 2025

Feb 18, 2025

BioCryst up 8% after raising 2024 Orladeyo revenue guidance - MSN

Feb 18, 2025

Feb 17, 2025

BioCryst Pharmaceuticals (BCRX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Yahoo Finance

Feb 17, 2025

Feb 17, 2025

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World

Feb 17, 2025

Feb 15, 2025

BioCryst Pharmaceuticals (NASDAQ:BCRX) Reaches New 12-Month HighTime to Buy? - MarketBeat

Feb 15, 2025

Feb 15, 2025

BioCryst Pharmaceuticals, Inc. to Host Earnings Call - ACCESS Newswire

Feb 15, 2025

Feb 15, 2025

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Shares Fly 25% But Investors Aren't Buying For Growth - Simply Wall St

Feb 15, 2025

Feb 14, 2025

BioCryst stock soars to 52-week high, touches $9.02 By Investing.com - Investing.com South Africa

Feb 14, 2025

Feb 13, 2025

Oral HAE treatment Orladeyo now available to patients in Portugal - Angioedema News Today

Feb 13, 2025

Feb 12, 2025

Portugal approves daily oral therapy for hereditary angioedema By Investing.com - Investing.com Nigeria

Feb 12, 2025

Feb 12, 2025

Portugal approves daily oral therapy for hereditary angioedema - MSN

Feb 12, 2025

Feb 12, 2025

BioCryst Says Orladeyo Recommended for Hereditary Angioedema Prevention in Portugal - Marketscreener.com

Feb 12, 2025

Feb 12, 2025

BioCryst Launches ORLADEYO® (berotralstat) in Portugal - The Manila Times

Feb 12, 2025

Feb 12, 2025

Breakthrough: Portugal Gets First-Ever Daily Oral HAE Treatment as ORLADEYO Expands Global Reach - StockTitan

Feb 12, 2025

Feb 11, 2025

Ebola Virus Vaccine Market May See a Big Move| Arbutus Biopharma, BioCryst Pharmaceuticals - openPR

Feb 11, 2025

Feb 11, 2025

BioCryst to Report Fourth Quarter 2024 Financial Results on February 24 - GlobeNewswire

Feb 11, 2025

Feb 11, 2025

Where are the Opportunities in (BCRX) - Stock Traders Daily

Feb 11, 2025

Feb 10, 2025

BioCryst to Present New ORLADEYO® (berotralstat) Results - GlobeNewswire

Feb 10, 2025

Feb 10, 2025

Exploring Three High Growth Tech Stocks In The United States - Simply Wall St

Feb 10, 2025

Feb 10, 2025

BioCryst to Present New ORLADEYO® (berotralstat) Results from APeX-P Pediatric Trial at 2025 American Academy of Allergy, Asthma & Immunology / World Allergy Organization Joint Congress - The Manila Times

Feb 10, 2025

Feb 10, 2025

BCRX Unveils Groundbreaking Pediatric Trial Data: ORLADEYO Shows Promise in Children Under 12 - StockTitan

Feb 10, 2025

Feb 10, 2025

BioCryst (BCRX) Q4 Earnings Call: Key Financial Updates Coming February 24Here's What to Track - StockTitan

Feb 10, 2025

Feb 09, 2025

BioCryst Pharmaceuticals (NASDAQ:BCRX) Hits New 12-Month HighShould You Buy? - MarketBeat

Feb 09, 2025

Feb 09, 2025

BioCryst Pharmaceuticals Sees Unusually High Options Volume (NASDAQ:BCRX) - MarketBeat

Feb 09, 2025

Feb 09, 2025

BioCryst Pharmaceuticals (NASDAQ:BCRX) Shares Up 9.1%Still a Buy? - MarketBeat

Feb 09, 2025

Feb 08, 2025

SG Americas Securities LLC Sells 117,571 Shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) - MarketBeat

Feb 08, 2025

Feb 06, 2025

Investors Purchase High Volume of Call Options on BioCryst Pharmaceuticals (NASDAQ:BCRX) - Defense World

Feb 06, 2025

Feb 05, 2025

SG Americas Securities LLC Has $311,000 Holdings in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) - Defense World

Feb 05, 2025

Feb 05, 2025

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Sees Large Decrease in Short Interest - MarketBeat

Feb 05, 2025

Feb 04, 2025

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Feb 04, 2025

Feb 04, 2025

Inside BioCryst's Latest Executive Compensation Move: Key Details on New Hire Stock Grants - StockTitan

Feb 04, 2025

Feb 04, 2025

BioCryst Pharmaceuticals (NASDAQ:BCRX) Given "Market Outperform" Rating at JMP Securities - MarketBeat

Feb 04, 2025

Feb 02, 2025

CPRX: 3 Niche Healthcare Stocks Tackling Rare Diseases - StockNews.com

Feb 02, 2025